| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Early detection of HTN and prevention of CV morbidity in predisposed children and adolescents |
| Risks, harm, cost | Time for and difficulty of conducting measurements |
| Benefit–harm assessment | Benefits exceed harm |
| Intentional vagueness | Frequency of evaluation |
| Role of patient preferences | Increased visit time, discomfort of cuff |
| Exclusions | Children and adolescents who are not at increased risk for HTN |
| Strength | Moderate recommendation |
| Key references | 27,46,107,110–112 |
| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Early detection of HTN and prevention of CV morbidity in predisposed children and adolescents |
| Risks, harm, cost | Time for and difficulty of conducting measurements |
| Benefit–harm assessment | Benefits exceed harm |
| Intentional vagueness | Frequency of evaluation |
| Role of patient preferences | Increased visit time, discomfort of cuff |
| Exclusions | Children and adolescents who are not at increased risk for HTN |
| Strength | Moderate recommendation |
| Key references | 27,46,107,110–112 |